Blog

Understanding the Issues with ADA Assays

Streamline Immunogenicity Assay Development_ Expedite Research Workflows by Understanding the Issues with ADA Assays

The biotech industry is rapidly modifying and developing biotherapeutics into complex large molecules with specificity moieties and multiple functional domains to produce a specific biological method of action. (ADC, ACC, Bi-specific antibodies, Fusion proteins, recombinant-modified proteins, etc.) Therefore, developing LBA assays to detect the immunogenicity of these biotherapeutics is becoming very complex due to this…

Read More...

Sword Bio Appoints John Pirro as Director of Scientific Solutions

Welcome to the team John Pirro, Director, Scientific Solutions with quote I am so excited to be part of helping our partners with scientific analytical solutions and working with the Sword team to help our clients bring biological therapeutics into the marketplace

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of John Pirro as Director of Scientific Solutions. John joins Sword with a proven track record in the contract research space, providing scientific insight, guidance, and consultation. Most recently, he…

Read More...